Members of the Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures: Jasvinder A. Singh, MD, MPH (Co-Chair), Daniel H. Solomon, MD, MPH (Co-Chair), Maxime Dougados, MD, David Felson, MD, MPH, Gillian Hawker, MD, MPH, Patricia Katz, PhD, Hal Paulus, MD, Carol Wallace, MD.
Development of classification and response criteria for rheumatic diseases†
Version of Record online: 31 MAY 2006
Copyright © 2006 by the American College of Rheumatology
Arthritis Care & Research
Volume 55, Issue 3, pages 348–352, 15 June 2006
How to Cite
CLASSIFICATION AND RESPONSE CRITERIA SUBCOMMITTEE OF THE AMERICAN COLLEGE OF RHEUMATOLOGY COMMITTEE ON QUALITY MEASURES (2006), Development of classification and response criteria for rheumatic diseases. Arthritis & Rheumatism, 55: 348–352. doi: 10.1002/art.22003
The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.
- Issue online: 31 MAY 2006
- Version of Record online: 31 MAY 2006
- Manuscript Accepted: 9 MAR 2006
- Manuscript Received: 3 MAR 2006
- American College of Rheumatology
Relevance to the clinician. Clinicians already know that not all patients who are diagnosed with rheumatic diseases really have them. Moreover, determining which patients have improved and by how much is also difficult. Classification criteria allow clinical researchers to recruit patients with similar diseases (e.g., rheumatoid arthritis or systemic lupus erythematosus) into studies. Response criteria help to determine whether treatments really work, i.e., whether they actually produce clinically important improvement. As the science of clinical research advances, we must update our standards for considering classification and response criteria. In this editorial, members of the American College of Rheumatology (ACR) Subcommittee on Classification and Response Criteria describe the purpose of criteria sets, their development and validation, and the role of the ACR in adopting them.